PTAB Newsletter

In this issue:

• Q&A with Arnold & Porter PTAB Practitioner Deborah Fishman
• Q&A with Arnold & Porter PTAB Practitioner Alice Ho
• Patent Eligibility Updates: New USPTO Report, Supreme Court Cert Denial, and Bill in Congress
• Recent District Court Case Regarding IPR Estoppel: Chemours Co. FC, LLC v. Daikin Indus., LTD, C.A. No. 17-1612, 2022 WL 2643517 (D. Del. July 8, 2022)
• Recent District Court Case Regarding the Scope of Collateral Estoppel: IOENGINE, LLC v. PayPal Holdings, Inc., C.A. No. 18-826-WCB, 2022 WL 2800861 (D. Del. June 15, 2022)
• Recent PTAB Case Regarding Fintiv Denial-PTAB Denies Institution of PGR Based On Fintiv, Institutes on Rehearing, Then Once Again Denies Based On Fintiv: Daiichi Sankyo, Inc. and AztraZeneca Pharmaceuticals, LP v. SeaGen Inc, PGR2021-00030
• Recent Changes in the Assignment of Patent Cases in W.D. Texas
• PTAB Boardside Chat Webinar: Request for Comments on Director Review, Precedential Opinion Panel Review, and Internal Circulation and Review of PTAB Decisions-August 11, 2022
• USPTO-FDA Interagency Collaboration and Disclosure Guidance 

© Arnold & Porter Kaye Scholer LLP 2022 All Rights Reserved. This newsletter is intended to be a general summary of the law and does not constitute legal advice. You should consult with counsel to determine applicable legal requirements in a specific fact situation.